Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Unsupported browser: Your browser does not meet modern web standards. See how it scores »

Gary Taubes Guest Contributor

  • Antibody Drug Revival

    The human immune system is still the best resource for fighting disease. After a decade of failed promise, drugs that exploit it are finally flooding the market.

  • The Virtual Cell

    With human cells distilled into digital models, testing the effectiveness of a new drug could be as simple as typing a few lines into a computer.

  • Postol vs. the Pentagon

    Ted Postol is challenging the government’s claims about a proposed a missile defense system. He’s a prickly character, but he has a track record that’s hard to beat.

  • Whose Nuclear Waste?

    Yucca Mountain in Nevada looked like the perfect place to stash the byproducts of nuclear power. Fifteen years and billions of dollars later, it’s not even close to being operational. Is starting from scratch the only option?

  • Speeding Drug Discovery

    It takes years and millions to get a new drug to market. New techniques might burrow through the mountain of genome data and break the bottleneck.

  • Your Genetic Destiny for Sale

    To find disease-causing genes, researchers want access to millions of personal medical records-maybe even yours. Is this necessary science or dubious profiteering?

  • The Cell-Phone Scare

    When fear is the opponent, science doesn’t stand a chance.

    1 comment

  • Telling Time by the Second Hand

    By emphasizing challenges to conventional wisdom, the popular press distorts how science really works.

From the Archives

Close

Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me